Health Trials

C-Met Exon 14 Mutation

1

Review clinical trials related to C-Met Exon 14 Mutation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

Indication:Patients with Advanced c-MET-positive Non-Small Cell Lung Cancer Phase Ib (China only): Approximately 90 patients Phase Ⅱ (globally): Approximately 78 evaluable patients; addition of at least 6 patients in Safety Run-in (US only)

Participants needed: 183
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Haihe Biopharma Co., Ltd.Updated: Aug 1, 2022Locations: 44
Eligibility criteria

Provide informed consent voluntarily. [+24]

Patients with targetable activating EGFR mutation, ALK rearrangement, ROS1 rearr... [+23]

Read more